CU Cancer Center News and Stories

When a person has lived with colorectal cancer for a long time, and gotten to the point of not responding to therapies as much or at all, it’s common to develop cachexia. This debilitating condition is a multi-systemic wasting syndrome that can cause weight loss, a loss of muscle and bone mass, fatigue, and frailty.

Rachel Sauer | September 30, 2022

Prostate cancer is the most common cancer in men and, when caught and treated early, is considered curable. But when prostate cancer becomes metastatic, meaning it spreads to distant organs, it is no longer considered curable and novel treatment strategies are needed.

Rachel Sauer | September 28, 2022

Prostate cancer is the second most common and deadly cancer in the United States. The American Cancer Society estimates that 1 in 8 men will receive a prostate cancer diagnosis in their lifetime. Treatment techniques range from aggressive therapies such as radical prostatectomy or radiation therapy to targeted therapies that treat only the affected cancer cells.

Noelle Musgrave | September 26, 2022

Every person who receives a cancer diagnosis experiences the symptoms of the disease and treatments differently. However, a common thread is that the disease can influence every aspect of life, even after a person reaches no evidence of disease (NED) status.

Rachel Sauer | September 23, 2022

People often tell Winona Williams that she’s brave, and she is. Ovarian cancer could easily become a dark cloud over her, shadowing every minute of every day.

Rachel Sauer | September 20, 2022

Thanks in part to clinical trials overseen by researchers at the University of Colorado Cancer Center, a wearable, portable electrical device called Optune is proving successful at treating a type of brain tumor called a glioblastoma.

Greg Glasgow | September 19, 2022

September is Blood Cancer Awareness Month, a time for bringing attention to leukemia, lymphoma, myeloma, Hodgkin’s disease, and other blood cancers.

Greg Glasgow | September 16, 2022

As part of its ongoing efforts to eradicate childhood cancers, the St. Baldrick’s Foundation has awarded University of Colorado Cancer Center member Kelly Faulk, MD, a St. Baldrick’s Scholar grant to investigate a new method for treating infant leukemia. 

Greg Glasgow | September 08, 2022

A new phase 2 clinical trial led by University of Colorado Cancer Center member Robert Lentz, MD, may offer hope for patients with metastatic colon cancer for whom standard therapy is no longer effective. Lentz is mentored by Wells Messersmith, MD, associate director of clinical services at the CU Cancer Center.

Greg Glasgow | September 07, 2022

As genetic counseling and genetic testing continue gaining importance in the world of cancer, the new co-director of hereditary cancers in the University of Colorado Cancer Center is aiming to increase awareness of these important resources for patients.

Rachel Sauer | September 06, 2022

The prostate-specific antigen (PSA) is a protein produced by the prostate gland. The PSA test is a blood test used to measure the amount of this protein found in the blood. Results are reported (ng/mL), which means nanograms of PSA per milliliter of blood. High levels of PSA have been found in men with advanced prostate cancer. 

Noelle Musgrave | September 02, 2022

Initially, the big picture looks severe: Pediatric brain tumors are now the number one cause of death for children diagnosed with cancer.

Though leukemia is four times more common in pediatric patients than brain tumors, about 90% of children diagnosed with leukemia will experience a cure “because we’ve done such a good job of researching leukemia, and treatments have come so far that cure rates have improved significantly,” says Rajeev Vibhakar, MD, PhD, MPH, a professor of pediatric hematology and oncology in the University of Colorado School of Medicine. “We need to see that same level of support and advancement in finding cures for pediatric brain tumors.”

Rachel Sauer | September 01, 2022

In research that reinforces the University of Colorado Cancer Center’s longstanding relationship with the Leukemia & Lymphoma Society (LLS), CU Cancer Center member Lauren Nicholas, PhD, MPP, is co-principal investigator on a new LLS-funded study to examine the role of Medicare plan selection in dealing with a blood cancer diagnosis.  

Greg Glasgow | August 30, 2022

Each year, about 27,000 women age 45 or younger are diagnosed with breast cancer in the United States. Of those, about 4% are pregnant at the time of their diagnosis.

Rachel Sauer | August 27, 2022

Researchers at the University of Colorado Anschutz Medical Campus have discovered how to extract critical information about breast cancer tumors and disease progression by analyzing blood plasma rather than using more invasive tissue biopsies.

“This is simply a blood draw,” said the study’s senior co-author Peter Kabos, MD, associate professor of medicine in the medical oncology division at the University of Colorado School of Medicine and CU Cancer Center member. “This allows us to look under the surface to see the defining characteristics of the disease. The advantage is that we don’t need to do repeated tissue biopsies.”

David Kelly | August 25, 2022

Deaths from COVID-19 and drug overdoses grabbed a lot of the headlines in 2021, but recently released numbers from the Colorado Department of Public Health and Environment show that cancer was still a leading cause of death in the state, and the number-one cause of death for the 45–84 age range.  

Greg Glasgow | August 22, 2022

For Isaiah Richardson, conducting research as an American Cancer Society Diversity in Cancer Research Intern this summer was an important academic and professional experience, but it was also personal.

Rachel Sauer | August 18, 2022

Less than a year ago, Ken Herfert got a puppy and named her Bailey after the Colorado town where she was born.

This was a big deal for several reasons, including the responsibility of adopting a new family member, but perhaps the biggest was this: About six months after receiving a diagnosis of esophageal cancer in early 2018, Herfert’s oncologist in California told him he had maybe a year to live, maybe less.

Rachel Sauer | August 16, 2022

The effects of cancer are not just physical, especially in advanced stages of the disease. People living with a cancer diagnosis may experience depression, anxiety, and fear, or feel demoralized by the weight of new and unanticipated burdens.

Rachel Sauer | August 15, 2022

For many researchers, the end of a post-doctoral fellowship and entry into a junior faculty position can be a time without a map.

Rachel Sauer | August 12, 2022

Among the biggest obstacles in studying and treating brain tumors are the blood-brain and blood-tumor barriers (BBTB). Generally, just a small amount of drug that is injected into the blood to treat brain tumors is able to penetrate blood vessel walls and accumulate in the brain.

Rachel Sauer | August 10, 2022

After a 30-year, off-and-on battle with metastatic breast cancer, Australian-born actress and singer Olivia Newton-John died on August 8 at age 73. Best known for her role as Sandy in the 1978 movie musical “Grease,” Newton-John also hit the music charts with singles like “Physical” and “Magic.” 

Greg Glasgow | August 09, 2022

A cancer diagnosis can be difficult to work through in the best of circumstances, but factor in barriers related to language, insurance status, educational achievement, geographic location, income level, and more, and the cancer journey — everything from prevention and screening to diagnosis and treatment — can become nearly impossible to traverse. 

Greg Glasgow | August 05, 2022

When the 21^st Century Cures Act went into effect in April 2021, health care organizations began releasing electronic health information (EHI) to patients immediately.

Rachel Sauer | August 04, 2022

A new study released by the University of Colorado Cancer Center shows that more than 70 percent of breast cancer patients have reported changes that affect their sexual health during and beyond treatment.

Laura Kelley | August 02, 2022

Until 2007, about 1 in 20 lung cancer patients all had the same thing in common but did not know it.

Rachel Sauer | August 01, 2022

For people living with and beyond cancer, one of the most common and limiting side effects is cancer-related fatigue (CRF).

Rachel Sauer | July 29, 2022

A new study from the University of Colorado Cancer Center explores which lung cancer patients are the best candidates for novel therapies that directly target a gene identified as driving certain cancers.

Julia Milzer | July 27, 2022

Some 100 researchers from around the world were in Aurora last week to discuss the latest findings and news around Kaposi sarcoma herpesvirus (KSHV), the virus that causes a type of cancer known as Kaposi sarcoma.  

Greg Glasgow | July 21, 2022

The bad news about endometrial cancer — cancer that begins in the lining of the uterus — is that it is one of the few cancers that is increasing in incidence even as most other cancers are on the decline, thanks to advances in treatment and prevention.  

Greg Glasgow | July 18, 2022

Large B-cell lymphoma (LBCL) is one of the most aggressive lymphomas and accounts for about 30% of all lymphoma diagnoses.

Rachel Sauer | July 14, 2022

Oncologists have many tools they use to treat cancer, and one of the most commonly used is radiation therapy. In use since the early 1900s, radiation therapy uses high-energy particles or waves — including x-rays, gamma rays, electron beams, and protons — to destroy or damage cancer cells. The machine that delivers radiation therapy has a head that rotates 360 degrees, and patients lie on a special bench that swivels, allowing the radiation to be delivered from any angle.

Greg Glasgow | July 13, 2022

Ward McNeilly thought he was a goner.  

It was summer 2021, and the sarcoma that had started in the Denver resident’s left thigh seemed to be under control, subdued by radiation and chemotherapy following a surgery in 2018 to remove the initial tumor and another surgery in 2019 to remove cancerous tumors in his groin. McNeilly was doing so well, in fact, that his doctors at UCHealth University of Colorado Hospital authorized a “chemo vacation” to give his body a break from some of the side effects of the treatment.

Greg Glasgow | July 11, 2022

Artificial intelligence (AI) can be used to reduce the number of biopsies of benign thyroid nodules, according to new research from University of Colorado Cancer Center member Nikita Pozdeyev, MD. 

Greg Glasgow | July 08, 2022

An exciting and innovative area of cancer research is immunoprevention, in which studies focus on preventing cancer before its onset by using vaccines, antibodies, and other immune mechanisms.

Rachel Sauer | July 06, 2022

Three University of Colorado Cancer Center scientists have received a combined total of almost $2 million in grant funding from the American Cancer Society (ACS) to support research addressing a broad spectrum of cancer prevention, diagnosis, and treatment.

Rachel Sauer | July 01, 2022

Artificial intelligence and machine learning are among the latest tools being used by cancer researchers to aid in detection and treatment of the disease.

Greg Glasgow | June 29, 2022

University of Colorado Cancer Center researchers from the Anschutz and Boulder campuses are collaborating on a broad range of research that recently received AB Nexus support.

Rachel Sauer | June 24, 2022

PIK3CA is a gene that makes an enzyme called PI3K, which is involved in many important cell functions. When PIK3CA mutates, however, it can make the PI3K enzyme become overactive and cause cancer cells to grow.

Rachel Sauer | June 22, 2022

As they both deal with a stage IV colon cancer diagnosis, Kacie Peters and Erik Stanley are focused on living a normal, happy life with their son.

Rachel Sauer | June 20, 2022

Country music star Toby Keith has been battling stomach cancer, also known as gastric cancer, for the past six months, he announced Sunday on social media.

Rachel Sauer | June 14, 2022

Jimmy Guerrero’s first diagnosis was a possible stomach ulcer, because it seemed inconceivable that a 26-year-old would have colon cancer.

Rachel Sauer | June 13, 2022

Richard Duke, PhD, is taking the next step in his long career at the University of Colorado School of Medicine, joining the CU Cancer Center this July as deputy associate director of commercialization. In his new role, Duke will serve as a liaison to center-level oversight, strategic planning, and process improvement for CU Cancer Center commercialization efforts, working closely with CU Innovations and the Colorado AMC SPARK/REACH program.  

Greg Glasgow | June 10, 2022

Researchers have discovered that infiltrating gliomas, a common brain and spinal cord tumor, are shaped by their genetic evolution and microenvironment, a finding that could lead to more targeted treatments.

David Kelly | June 09, 2022

Bringing with him more than 20 years of experience in gene therapy and personalized medicine, Hatim Sabaawy, MD, PhD, will step into the role of associate director of translational research at the University of Colorado Cancer Center on July 1.

Greg Glasgow | June 08, 2022

In recognition of National Cancer Survivors Day on June 5, we wanted to share how far cancer survivorship has come, our efforts at the University of Colorado Cancer Center to further the research that results in survivorship, and some of our survivor stories from the past year.

Shelly Lange | June 03, 2022

The median age for receiving a bladder cancer diagnosis is 73, and a significant number of those living with the disease are in their 70s and 80s.

Rachel Sauer | June 01, 2022

Colorado is known for adventure – from kayaking to skiing, horseback riding to rock climbing, and everything in between. These sports take full advantage of the beauty and challenge of Colorado’s landscape, and often come to define a group of like-minded and spirited individuals who share a passion for adrenaline, community, and focus.

Carolyn Wilson | May 27, 2022

Four research projects conducted by University of Colorado Cancer Center members from the University of Colorado Anschutz Medical Campus and Colorado State University recently each received $50,000 pilot grant funding from the Joint Pilot Program of the CU Cancer Center and CSU Flint Animal Cancer Center.

Rachel Sauer | May 26, 2022

Molly the golden retriever was a fan of cookies. Whenever there was a plate of them nearby, she kept her eye on it, waiting for her chance to sneak one or five. She was a fan of water, too, even after she had surgery to remove her left front leg following an osteosarcoma, or bone cancer, diagnosis in April 2017.

Rachel Sauer | May 19, 2022

Among the many lessons collectively learned during the initial months of the worldwide COVID-19 pandemic was this: The experience was uncharted psychological and emotional terrain. It wasn’t uncommon for people across the globe to express uncertainty about how to navigate new stresses and new emotions.

Rachel Sauer | May 16, 2022

She was recognized by her peers in 2021 for her leadership at the University of Colorado Cancer Center’s Animal Imaging Shared Resource. Now Natalie Serkova, MSc, PhD, is bringing her expertise to a new role: deputy associate director of all shared resources at the CU Cancer Center.  

Greg Glasgow | May 11, 2022

Hormone therapy is often used to treat prostate cancer that has spread to other parts of the body, but many patients develop resistance to hormone therapy, causing their disease to become more aggressive and potentially more deadly. 

Greg Glasgow | May 10, 2022

 University of Colorado Cancer Center member Janet Kukreja, MD, assistant professor of urology in the University of Colorado School of Medicine, is taking part in this weekend’s Walk to End Bladder Cancer along with her office staff, fellow physicians, and even some of her patients. For this year’s “virtual” event, hosted by the Bladder Cancer Advocacy Network to kick off Bladder Cancer Awareness Month in May, participants walk in their own cities at their own pace, sharing their progress with others around the country. 

Greg Glasgow | May 06, 2022

Michael Joseph Roark – Mike to his friends – met Mary Jo Dougherty in a ski fitness class taught by Anne Kashiwa at the former International Athletic Club in downtown Denver.

Rachel Sauer | May 05, 2022

Receiving a cancer diagnosis can feel like crossing the border into a new country, one with its own language, customs, and laws. Following a cancer diagnosis, people may find themselves sprinting to absorb a new vocabulary of often intimidating words.

Rachel Sauer | May 04, 2022

There are four broad categories of cancer research. The University of Colorado Cancer Center has researchers working in each of these four areas, collaborating to prevent and conquer cancer.

Cancer Center | May 02, 2022

This year, lung cancer will account for an estimated 130,000 deaths in the United States – approximately 25% of all cancer deaths. Among those deaths, people who are Black will be disproportionately represented.

Rachel Sauer | April 29, 2022

 As a former dancer and dance instructor, CU Cancer Center member Jennifer Raybin, PhD, knows the power the creative arts hold to help people through challenging times. As a nurse practitioner who led the Palliative Care Program at Children’s Hospital Colorado, she knows the creative arts can be especially helpful for children and young adults with cancer. Creative activities help patients deal with symptoms, improve their mood, and even ease disease and treatment symptoms like pain, nausea, and fatigue.

Greg Glasgow | April 28, 2022

The development of the anti-cancer immunotherapy drugs called immune checkpoint inhibitors has improved treatment for many cancer patients, but patients with mucosal melanomas — melanomas that occur not on the skin but in the mucous membranes in the head, neck, eyes, respiratory tract, and genitourinary region — are particularly resistant to immune checkpoint inhibitors for reasons researchers don’t fully understand. 

Greg Glasgow | April 25, 2022

To understand why Beau Gill built a mental cupboard for Jeff and Spike, first you must travel back with him to the small town of Catemaco in Mexico’s state of Veracruz.

Rachel Sauer | April 20, 2022

At first blush, the numbers aren’t great: Cancer patients who are covered by Medicaid tend to have later-stage disease and higher rates of mortality.

Greg Glasgow | April 13, 2022

April has been designated National Minority Cancer Awareness Month to bring attention to the health disparities that lead to higher rates of cancer in Black, Hispanic, American Indian/Alaskan Native, and other communities of color. 

Greg Glasgow | April 08, 2022

An enzyme that has been identified as instrumental in the progression of many types of cancer is meeting its match in inhibitors synthesized and evaluated by University of Colorado (CU) Cancer Center researchers.

Rachel Sauer | April 04, 2022

The National Cancer Institute (NCI) has once again recognized the University of Colorado (CU) Cancer Center as one of the best cancer centers in the country. On March 31, the NCI officially renewed the CU Cancer Center’s “comprehensive” designation with a strong rating, the best ever received at the CU Cancer Center. The award recognizes the center’s strengths in basic, translational, clinical, and population science research, as well as leadership and resources devoted to community outreach and engagement and cancer research, training, and education.

Greg Glasgow | March 31, 2022

For so many years, Kelly Noonan prioritized a lot of elements in her life – her family, her career as a nurse, her friends, her responsibilities as a community volunteer.

Rachel Sauer | March 28, 2022

While conducting research for her doctoral dissertation, Channing Tate, PhD, MPH, spoke with 144 older Black adults about hospice care – what they knew about it, whether they’d consider it, what their experiences with hospice had been.

Rachel Sauer | March 25, 2022

Colorectal cancer, the third most commonly-diagnosed cancer in the United States (excluding skin cancers) and second leading cause of cancer-related mortality, is increasingly affecting people in their 20s and 30s, recently published research shows.

Rachel Sauer | March 23, 2022

University of Colorado (CU) Cancer Center member Tejas Patil, MD, is one of three researchers to receive a combined $1 million grant from the Hamoui Foundation and LUNGevity Foundation to study RET-positive lung cancer. 

Greg Glasgow | March 21, 2022

A University of Colorado (CU) Cancer Center researcher has found, through extensive data analysis, that the youngest patients with brain tumors – those ages birth to 3 months – have about half the five-year survival rate as children ages 1 to 19.

Rachel Sauer | March 18, 2022

When Myles Krick started his freshman year of college in fall 2021, he couldn’t help but look back to 15 years ago, when he received the brain cancer diagnosis that made his family worry he might not live long enough to go to college. 

Greg Glasgow | March 16, 2022

Dianne Primavera wouldn’t take no for an answer.  

Greg Glasgow | March 07, 2022

In normal human development, the SIX1 gene is critical for embryonic muscle development. After a person is born and as they mature, SIX1 is downregulated, or becomes less prevalent in cells.

Rachel Sauer | March 02, 2022

March is Kidney Cancer Awareness Month, and to get the latest information on the disease, we spoke with University of Colorado (CU) Cancer Center member Elaine Lam, MD, FACP, an associate professor of medicine in the Division of Medical Oncology at the University of Colorado School of Medicine. 

Greg Glasgow | March 02, 2022

University of Colorado (CU) Cancer Center researchers have been on the leading edge of developing new therapies for leukemia. One of the most recent breakthrough therapies has been the development of venetoclax, a B-cell lymphoma-2 inhibitor, that that has shown profound results for adults with acute myeloid leukemia (AML) and has become a standard of care for patients with this disease all over the world.

Rachel Sauer | February 24, 2022

There were a lot of things Jim White thought he’d never do: stay in one place long enough to feel roots grow beneath his feet, meet the love of his life, have a child whose daily joy in discovering the world reignites White’s own joy.

Rachel Sauer | February 22, 2022

Even as exciting developments are happening in cervical cancer research, an estimated 14,100 new cases of invasive cervical cancer will be diagnosed in the United States this year.

Rachel Sauer | February 16, 2022

The University of Colorado Cancer Center is pleased to announce that Marie Wood, MD, has been named the medical director of the Cancer Clinical Trials Office (CCTO).

Rachel Sauer | February 11, 2022

The Tumor-Host Interactions Program (THI) at the University of Colorado Cancer Center has awarded four CU Cancer Center researchers $30,000 each to gain preliminary data using the Multiplex Ion Beam Imager (MIBI) housed in the cancer center’s Human Immune Monitoring Shared Resource (HIMSR) to support a competitive national grant proposal. The selected researchers are expected to submit a national competitive grant proposal within six months of completing their THI-MIBI pilot studies.  

Greg Glasgow | February 10, 2022

Can dietary strategies like intermittent fasting or time-restricted eating help breast cancer survivors prevent their tumors from recurring? It’s a question researchers at the University of Colorado (CU) Cancer Center are looking to answer with a new study funded by a $3 million R01 grant from the National Cancer Institute.

Greg Glasgow | February 09, 2022

On a mission to increase early detection of esophageal cancer, University of Colorado (CU) Cancer Center member Sachin Wani, MD, is leading a study to see if a novel diagnostic platform can help endoscopists better identify the disease in patients with a condition called Barrett’s esophagus.

Greg Glasgow | February 07, 2022

On this World Cancer Day, the University of Colorado (CU) Cancer Center looks back to earlier this week when President Biden reignited his Cancer Moonshot initiative, setting ambitious goals to “reduce the death rate from cancer by at least 50% over the next 25 years and improve the experience of people and their families living with and surviving cancer — and by doing this and more, end cancer as we know it today.” 

Shelly Lange | February 04, 2022

University of Colorado (CU) Cancer Center leader Wells Messersmith, MD, has been named chief medical officer of oncology services at UCHealth. In this new role, Messersmith will oversee cancer care at all UCHealth locations with a focus on expanding advanced treatments and the clinical trials UCHealth offers in partnership with the CU Cancer Center.

Cancer Center | January 27, 2022

 Comedian Louie Anderson — known for his stand-up routines, as well as a hosting stint on “Family Feud,” his animated series “Life With Louie,” and a more recent role on the FX comedy series “Baskets” — died January 21of diffuse large B-cell lymphoma. He was 68.

Greg Glasgow | January 25, 2022

When Colorado Governor Jared Polis declared January National Radon Action Month, he noted that about 50 percent of Colorado homes test at or above the guideline level at which the U.S. Environmental Protection Agency (EPA) recommends remediation.

Rachel Sauer | January 20, 2022

Two research investigations being led by University of Colorado Cancer Center researchers are receiving grant support this year from Wings of Hope for Pancreatic Research.

Rachel Sauer | January 19, 2022

The American Cancer Society (ACS) released its annual cancer statistics last week, reporting that the risk of dying from cancer in the U.S. has fallen 32% over the past 28 years. Cancer deaths in the U.S. reached their peak in 1991, with 215 out of every 100,000 people dying from cancer, and have been falling ever since, largely due to a decline in the amount of people who smoke.

Greg Glasgow | January 18, 2022

Three research teams at the University of Colorado Cancer Center have received $50,000 grants from the Denver Chapter of Golfers Against Cancer to support their research in fighting the disease.

Greg Glasgow | January 13, 2022

Carlos J. Castro transferred his care to Elizabeth Kessler, MD, University of Colorado Cancer Center member, after learning about a clinical trial that gave him a new treatment option for his stage 4 prostate cancer.

Cancer Center | January 12, 2022

In the past, molecular and cellular oncology research often began with the idea that cells are cells and proteins are proteins, and it didn’t especially matter who provided the sample.

Rachel Sauer | December 22, 2021

“Maybe this getting older thing just sucks and that’s how it is.”

Rachel Sauer | December 17, 2021

This was another exciting year for the University of Colorado Cancer Center, and we were able to share more than 80 stories spotlighting our members and their research. We also shared the cancer journeys of some of our patients.

Cancer Center | December 16, 2021

Some battles begin before a shot is even fired, with an army building bridges and grading roads, clearing and smoothing the path to make the invading force stronger and more effective.

Rachel Sauer | December 14, 2021

Of the 18,000 people diagnosed with large B-cell lymphoma each year, only half will be successfully treated with chemotherapy. The 9,000 remaining patients typically have poor outcomes, with only 25% responding to additional, higher-intensity chemotherapy, followed by a stem cell transplant.

Greg Glasgow | December 13, 2021

The University of Colorado Cancer Center is pleased to announce several leadership transitions that will support the center in its mission to overcome cancer through innovation, discovery, prevention, early detection, multidisciplinary care, and education.

Rachel Sauer | December 10, 2021

It’s worth noting, in light of recently published research, that a majority of people won’t be diagnosed with cancer in their lifetimes. According to the National Cancer Institute, about 40% of people will, which means 60% won’t.

Rachel Sauer | December 03, 2021

Sandra Luna-Fineman, MD, treats children and adolescents with cancer from around the U.S. in her role as a pediatric oncologist at Children’s Hospital Colorado, but she knows that children in low- and middle-income countries around the world need her help the most.

Greg Glasgow | December 01, 2021

At her lowest point, after hearing there wasn’t much more that medicine or science could do for her, Connie Walters asked her best friend and ex-husband, Abel, to stay with her overnight. She wasn’t sure she would wake up and she didn’t want to die alone.

Rachel Sauer | November 30, 2021

Looking to improve methods to treat patients with sepsis, Richard Tobin, PhD, an assistant research professor of surgical oncology in the University of Colorado School of Medicine, and Laurel Hind, PhD, an assistant professor in the biomedical engineering program at the University of Colorado Boulder, are teaming up to study the role of myeloid-derived suppressor cells (MDSCs) in sepsis.

Greg Glasgow | November 29, 2021

Two University of Colorado Cancer Center physicians have been recognized as world experts in in pancreatic neoplasms by the 2021 Expertscape rankings.

Rachel Sauer | November 19, 2021

One of the primary tools that oncologists use to stage cancers is the PET (positron emission tomography) scan, an imaging test that uses a small amount of radioactive sugar to detect metabolically active areas within the body.

Greg Glasgow | November 18, 2021

Lung cancer screening is recommended only for those who are at high risk for the disease — adults ages 50­–80 who smoke at least 20 packs a year — but even among members of that high-risk group, screening rates remain low, ranging from 5% to 20% of those eligible for the screening CT scan.

Greg Glasgow | November 15, 2021

It was just a cough – a nagging one, sure, but nothing too serious, Duane Cerniglia thought. Give it some time and it will go away.

Rachel Sauer | November 12, 2021

“When you lose hope, you lose everything,” says Ron Randolph. “It’s like you’re in the bottom of a hole and you see this light at the top of the hole. It’s a very small light, but there’s no way to escape.”

Greg Glasgow | November 11, 2021

Janice Woodward was already a member of the club nobody wants to join — the cancer club, membership involuntary — when she got an irregular mammogram result in May 2019.

Rachel Sauer | November 08, 2021

The cancer diagnosis came at a time when it seemed as though everything was happening – he was only 37 and soon to become president of the Denver City Council; his three children were ages 4, 6, and 9; he had just run the BOLDERBoulder 10K.

Rachel Sauer | November 03, 2021

There are two things most people believe about lung cancer, says Jamie Studts, PhD, co-leader of the Cancer Prevention & Control Program at the CU Cancer Center: Those who suffer from it most likely caused it by using tobacco, and the prognosis for surviving the disease is poor.

Greg Glasgow | November 02, 2021

When a woman receives a breast cancer diagnosis, she may have many questions about her immediate future – the stage of the disease, what treatment she’ll receive, where it will happen.

Rachel Sauer | October 22, 2021

Three researchers from the University of Colorado Cancer Center have received grants from the V Foundation, a cancer research nonprofit founded in 1993 by college basketball coach Jimmy Valvano, who died of cancer.

Greg Glasgow | October 20, 2021

In a grim reminder of the toll COVID-19 can take even among those who are vaccinated against it, former Secretary of State Colin Powell died Monday of complications from the virus. His family said Powell, who was 84, was fully vaccinated against the disease.

Greg Glasgow | October 18, 2021

The first time Caley Kurchinski had to think about a double mastectomy, she was only 16. Her mother had died at age 36 from breast cancer, when Caley was 6. When she became a teenager, Caley’s family physician began telling her she needed to get genetic testing.

Rachel Sauer | October 15, 2021

Erica Ramsthaler was only given three years to live when she was first diagnosed with colorectal cancer, but after transferring her care to the University of Colorado Cancer Center, she is thriving more than four years later.

Greg Glasgow | October 08, 2021

Kirsten Stewart was just putting on lotion, like she does every morning after her shower. That particular morning, though, she noticed something different: a lump that hadn’t been there before and that definitely wasn’t normal. She was only 30 years old.

Rachel Sauer | October 07, 2021

Tommy Stewart was already a prostate cancer survivor when, during his annual physical in 2004, his physician felt a nodule on his neck.

Rachel Sauer | October 04, 2021

The cancer survivorship journey can have many components, but one of the most important is regular exercise. Physical activity for individuals who have completed cancer treatment can build stamina, reduce anxiety, improve quality of life and physical fitness, and even improve survival outcomes.

Greg Glasgow | October 01, 2021

One of the reasons why cancer continues developing and growing is not just because cancer cells exist, but because they can recruit help from the body’s own blood vessels, stromal cells, and immune cells.

Rachel Sauer | September 30, 2021

 It’s one of the most heartbreaking things Adam Green, MD, sees as a pediatric oncologist: children who beat their cancer, only to see an incurable brain tumor arise five years later.

Greg Glasgow | September 28, 2021

Actor Willie Garson was probably best known for his role as Stanford Blatch on “Sex and the City,” playing one of Carrie Bradshaw’s New York-savvy best friends.

Rachel Sauer | September 27, 2021

Recent advances in immunotherapy have allowed doctors at the University of Colorado Cancer Center to more effectively treat melanomas that spread to other parts of the body. Immunotherapy drugs such as checkpoint inhibitors, which are commonly used to treat melanomas, work to strengthen a patient’s immune system so that it can prevent a tumor from “turning off” the ability of the immune system to fight it.

Greg Glasgow | September 23, 2021

A crucial challenge in cancer research is figuring out how to make immunotherapies more effective, channeling, and selectively guiding the body’s own immune responses in targeting and killing tumors.

Rachel Sauer | September 21, 2021

Breast cancer patients whose cancer spreads to the brain may soon have new treatment options, thanks to research led by CU Cancer Center member Diana Cittelly, PhD.

Greg Glasgow | September 20, 2021

University of Colorado Cancer Center member M. Eric Kohler, MD, PhD, was awarded a three-year, $270,650 Young Investigator Grant from CureSearch for Children’s Cancer, in partnership with the SebastianStrong Foundation, to develop a new treatment approach for acute myeloid leukemia (AML), a rare blood cancer in children.

Greg Glasgow | September 17, 2021

Comedian and former “Saturday Night Live” cast member Norm MacDonald died Tuesday, after what his brother, Neil MacDonald, described as a nine-year battle with acute leukemia. Norm MacDonald, known for his intelligence and sarcastic wit, was 61.

Greg Glasgow | September 16, 2021

Looking to understand why some brain tumors with a specific mutation can start to reject drugs commonly used to treat them, CU Cancer Center member Jean Mulcahy Levy, MD, led researchers from institutions around the country — including several from the University of Colorado School of Medicine — to study samples of brain tumors before and after being treated with the drug.

Greg Glasgow | September 15, 2021

Evan Conant was one of the lucky ones. His stage I colon cancer was caught early, during a routine colonoscopy, and doctors at the University of Colorado Cancer Center were able to perform a surgery to remove the tumors entirely.

Greg Glasgow | September 14, 2021

One of the most impactful advancements during the past decade in treating ovarian cancer is the use of PARP inhibitors (short for poly adenosine diphosphate-ribose polymerase). PARP inhibitors are a type of cancer drug that blocks the PARP enzyme from helping to repair DNA damage in cancer cells.

Rachel Sauer | September 13, 2021

When Dara Aisner, MD, PhD, an associate professor in the Department of Pathology at the University of Colorado School of Medicine, was approached by a colleague at another university about splitting the cost of a bulk purchase of new clinical testing products, she initially declined. Although it would be a valuable resource — and might even save her lab money in the long-term — the short-term cost was prohibitive.

Valerie Gleaton | September 07, 2021

The diagnosis came as a shock. Although, looking back, Bill Mordecai says it shouldn’t have been. 

Valerie Gleaton | September 01, 2021

After suffering from painful bouts of pancreatitis for more than a decade, Christina Gonzalez felt resigned to a seemingly endless cycle of procedures.

Valerie Gleaton | August 31, 2021

The doctors she saw initially didn’t seem too concerned, but 22-year-old Ella Neal knew something was seriously wrong. A persistent, unusual abdominal pain was keeping her up at night and distracting her from her studies at the University of Colorado Boulder.

Greg Glasgow | August 25, 2021

David Kooyman transferred his care to University of Colorado Cancer Center member and associate professor of thoracic oncology, Tejas Patil, MD, to be part of a clinical trial to help with his rare lung cancer gene fusion.

Cancer Center | August 19, 2021

Richard Schulick, MD, MBA, director of the University of Colorado Cancer Center, becomes close with all of his patients, but he has a special bond with Gerry Turner, one of Schulick’s surgical patients for pancreatic cancer.

Greg Glasgow | August 18, 2021

Despite the growing threat of the Delta variant, many Americans who have been vaccinated against COVID-19 are living life much as they did pre-pandemic — traveling, shopping, going out to eat, and forgoing masks in many situations.

Greg Glasgow | August 13, 2021

Comedian Kathy Griffin, 60, shared the news with the world Monday via Twitter: She was about to undergo surgery for stage I lung cancer.

Greg Glasgow | August 04, 2021

The Colorado Cancer Coalition launched the 2021­–2025 Colorado State Cancer Plan in the town of Cheyenne Wells on July 23, in concert with the Communities That Care Community Action Plan with Cheyenne County Local Public Health. More than 40 Cheyenne County residents joined in person, and nearly 100 more joined virtually. One of the Colorado Cancer Coalition's main priorities is to focus on increasing capacity and screening rates in rural and frontier counties. Over the past year, the coalition has focused on Cheyenne County, which has the second highest age-adjusted incidence rate of cancer in Colorado.

Cancer Center | July 30, 2021

Though the two main histological types of breast cancer — lobular and ductal — are treated with the same hormonal therapies, women with lobular breast cancer often have recurrence or metastasis of the disease several years after their initial treatment.

Greg Glasgow | July 28, 2021

When you ask a classroom full of middle schoolers what they want to be when they grow up, you’re likely to get a range of answers, from “pro athletes” and “astronauts” to “musicians” and “movie stars.”

Valerie Gleaton | July 26, 2021

The early days of the COVID-19 pandemic were an adjustment period for medical professionals across the board, but they brought up particular challenges for the Cancer Clinical Trial Office (CCTO) at the University of Colorado Cancer Center. A number of procedures that used to take place in person or in the office — collecting signatures from patients and doctors, delivering medications, submitting data to trial sponsors — suddenly had to be done in a whole new way.

Greg Glasgow | July 22, 2021

A study led by D. Ross Camidge, MD, PhD, director of thoracic oncology at the University of Colorado School of Medicine and CU Cancer Center member, has helped to define MET amplification as a rare but potentially actionable driver for non-small cell lung cancer (NSCLC).

Valerie Gleaton | July 19, 2021

It’s difficult enough when a loved one is diagnosed with cancer, but employed spouses of those who receive the diagnosis also are confronted with an array of practical problems. It’s now up to them to untangle issues around medical leave, health insurance, caregiving benefits, and more.

Greg Glasgow | July 14, 2021

Dmitri Simberg, PhD, an associate professor in the Department of Pharmaceutical Sciences in the Skaggs School of Pharmacy and a CU Cancer Center member, has released the results of a new study of the effectiveness of different types of fluorescent labels used to monitor the accumulation of liposomes in tumors.

Valerie Gleaton | July 08, 2021

As director of the Animal Imaging Shared Resource at the University of Colorado Cancer Center, Natalie Serkova, PhD, has played an integral part in many groundbreaking projects on the Anschutz Medical Campus.

Greg Glasgow | July 07, 2021

Nearly 30 researchers and physicians from the University of Colorado Cancer Center shared the results of their work at a June 15 online event titled “Collaborating to Conquer Cancer: A virtual conversation benefiting the CU Cancer Center.”

Greg Glasgow | July 06, 2021

All cells use the process of metabolism to turn nutrients into energy — including cancer cells. Metabolism is a fundamental function whose role in cancer is being explored by researchers across the CU Cancer Center.

Greg Glasgow | June 30, 2021